KLK6 and pancreatic ductal adenocarcinoma: Recent research has identified KLK6 as a promising prognostic biomarker in various cancers, while the co-expression of KLK6 and KLK10 has been suggested as a potential indicator of survival outcomes in pancreatic ductal adenocarcinoma [63].